Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 340 of 1,261
  1. US 11021469

    Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  2. US 11021468

    TGF-ß inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  3. US 11021458

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  4. US 11021454

    Type of aryl benzofuran amidated derivative and medical use thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  5. US 11021449

    Substituted triazoles and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  6. US 11021424

    Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

    PTC THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  7. US 11021435

    Serotonin receptor-targeting compounds and methods

    Northwestern University · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  8. US 11020510

    Muscle cell patches and uses therefor

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  9. US 11020492

    Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

    Sangamo Therapeutics, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  10. US 11020488

    Pyrroloquinolin compounds and methods of using same

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  11. US 11020479

    Method for production of solid water particles for homeopathy

    American Quantum Health Inc · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  12. US 11020470

    Virus-like particles

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  13. US 11020463

    Method of determining cellular protein homeostasis

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  14. US 11020461

    Methods and compositions for CNS delivery of arylsulfatase A

    Takeda Pharmaceutical Company Limited · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  15. US 11020483

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  16. US 11020459

    Factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  17. US 11020409

    Broad antiviral therapy with membrane modifying oxysterols

    The Regents of the University of California · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  18. US 11020417

    Methods and compounds for treatment of lymphocyte-related diseases and conditions

    Sarepta Therapeutics, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  19. US 11020458

    Factor VIII polymer conjugates

    Takeda Pharmaceutical Company Limited · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  20. US 11020438

    Phospholipid compositions and their preparation

    AKER BIOMARINE ANTARCTIC AS · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  21. US 11020402

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  22. US 11020391

    CRMP2 sumoylation inhibitors and uses thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  23. US 11020383

    Methods for the treatment of cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  24. US 11020373

    Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

    Amazentis SA · Granted Jun 1, 2021 · Expires May 27, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.